JCX-8-23 (May 09, 2023)

Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy

The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.”  The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.

 

Related Publications

  • JCX-10-25 (February 12, 2025)

    Income And Payroll Tax Offsets To Changes In Excise Tax Revenues For 2025–2035

    view details
  • JCX-1-25 (January 09, 2025)

    List Of Expiring Federal Tax Provisions 2024-2034

    view details
  • JCX-48-24 (December 11, 2024)

    Estimates Of Federal Tax Expenditures For Fiscal Years 2024-2028

    view details